OPTISON (human albumin microspheres and perflutren) by GE HealthCare is ultrasound contrast activity [moa]. Approved for contrast agent for ultrasound imaging [epc]. First approved in 1997.
Drug data last refreshed 16h ago · AI intelligence enriched 4w ago
OPTISON is an injectable ultrasound contrast agent composed of human albumin microspheres and perflutren gas that enhances visualization during cardiac ultrasound imaging. It works by creating echogenic microbubbles that reflect ultrasound waves, improving image quality and diagnostic accuracy. The drug is indicated for contrast-enhanced echocardiography in patients with suboptimal baseline images.
Product faces significant patent expiration within 1.6 years; commercial teams should expect revenue contraction and reduced headcount as LOE approaches.
Ultrasound Contrast Activity
Contrast Agent for Ultrasound Imaging
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals
Regadenoson Real Time Perfusion Imaging Trial-Optison
Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease
Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).
Worked on OPTISON at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moPatent cliff in ~2 years — expect lifecycle management and generic defense hiring
OPTISON offers limited career growth opportunities due to its advanced lifecycle stage and imminent patent expiration; roles are concentrated in field sales and brand management focused on defending market share rather than expansion. This is primarily a defensive commercial assignment suited for experienced professionals managing declining products or early-career professionals gaining tactical sales experience.